COSCIENS Biopharma (CSCIF) Total Assets by Year
COSCIENS Biopharma Inc closed fiscal year 2025 with $21.4M in total assets, $17.6M in total liabilities and $3.8M in shareholder equity. Total assets fell 38.9% from the prior fiscal year. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters COSCIENS Biopharma Inc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
CSCIF Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $21.4M-38.9% | $35.1M+47.7% | $23.7M-14.7% | $27.8M-65.2% | $80.1M+116.5% | $37.0M+85.2% | $20.0M-20.1% | $25.0M+12.7% | $22.2M-29.9% | $31.7M | N/A |
| Total Liabilities | $17.6M-19.7% | $21.9M+708.5% | $2.7M-32.6% | $4.0M-93.1% | $58.2M+144.5% | $23.8M+6.0% | $22.4M-2.9% | $23.1M-7.5% | $25.0M-1.8% | $25.4M | N/A |
| Total Equity | $3.8M-70.8% | $13.2M-37.4% | $21.0M-11.7% | $23.8M+8.6% | $21.9M+66.0% | $13.2Mn/m | -$2.5M-229.2% | $1.9Mn/m | -$2.8M-144.8% | $6.2M-71.3% | $21.6M |
CSCIF Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q4'2520-F | Q3'256-K | Q2'256-K | Q1'256-K | Q4'2420-F | Q3'246-K | Q2'246-K | Q1'246-K | Q4'2320-F | Q3'236-K | Q2'236-K | Q1'236-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $21.4M-38.9% | $23.9M-45.5% | $27.6M-44.9% | $31.1M-2.0% | $35.1M+47.7% | $43.8M+3.0% | $50.0M+7.7% | $31.8M-38.0% | $23.7M-14.7% | $42.5M-36.2% | $46.5M-35.3% | $51.3M-32.8% |
| Total Liabilities | $17.6M-19.7% | $18.8M-20.9% | $20.5M-14.1% | $21.0M+11.6% | $21.9M+708.5% | $23.8M+46.6% | $23.8M+36.9% | $18.8M-6.2% | $2.7M-32.6% | $16.2M-5.7% | $17.4M-0.7% | $20.1M-13.4% |
| Total Equity | $3.8M-70.8% | $5.1M-74.6% | $7.1M-72.9% | $10.1M-47.1% | $13.2M-37.4% | $20.0M-9.3% | $26.2M+12.2% | $19.2M-38.5% | $21.0M-11.7% | $22.1M-55.3% | $23.4M-57.0% | $31.2M-41.3% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More COSCIENS Biopharma Inc financials
Frequently Asked Questions
COSCIENS Biopharma Inc closed fiscal year 2025 with $21.4M in total assets, $17.6M in total liabilities and $3.8M in shareholder equity.
COSCIENS Biopharma Inc (CSCIF) total assets fell by 38.9% year over year, from $35.1M to $21.4M in fiscal year 2025.
COSCIENS Biopharma Inc (CSCIF) reported $21.4M in total assets in Q4 2025. This represents a decrease of 38.9% from the same quarter a year earlier.
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what COSCIENS Biopharma Inc (CSCIF) reported on that line in every period on record.